SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Aug-24 8:44 PM View: | Actuate Therapeutics, Inc. (ACTU) | 14-Aug-24 | Conversion | 9,380,700 | -- | -- | 100% 0 to 9.38M | |
14-Aug-24 8:44 PM View: | Actuate Therapeutics, Inc. (ACTU) | 14-Aug-24 | Private Purchase | 500,000 | $8.00 | $4,000,000.00 | 5% 9.38M to 9.88M | |
14-Aug-24 8:44 PM View: | Actuate Therapeutics, Inc. (ACTU) | 14-Aug-24 | Market Sale | 24,999 | $9.00 | $224,991.00 | (< 1%) 9.92M to 9.89M | |
14-Aug-24 8:44 PM View: | Actuate Therapeutics, Inc. (ACTU) | 14-Aug-24 | Exercise (in-the money or at-the-money) | 37,951 | $5.27 | $200,002.00 | < 1% 9.88M to 9.92M | |
11-Jun-24 9:33 PM View: | Cognition Therapeutics Inc (CGTX) | 07-Jun-24 | Grant Duplicate | 8,500 | -- | -- | < 1% 6.01M to 6.01M | |
28-May-24 10:00 PM View: | Lantern Pharma Inc. (LTRN) | 24-May-24 | Market Sale Duplicate | 20,000 | $6.33 | $126,600.00 | (2%) 1.25M to 1.23M | (17%) |
28-May-24 10:00 PM View: | Lantern Pharma Inc. (LTRN) | 23-May-24 | Market Sale Duplicate | 10,000 | $6.25 | $62,500.00 | (< 1%) 1.26M to 1.25M | (19%) |
29-Feb-24 9:54 PM View: | Lantern Pharma Inc. (LTRN) | 29-Feb-24 | Sale | 19,703 | $4.87 | $95,953.60 | (2%) 1.28M to 1.26M | |
29-Feb-24 9:54 PM View: | Lantern Pharma Inc. (LTRN) | 28-Feb-24 | Sale | 74,297 | $4.85 | $360,340.00 | (5%) 1.36M to 1.28M | |
29-Feb-24 9:54 PM View: | Lantern Pharma Inc. (LTRN) | 27-Feb-24 | Sale | 50,000 | $4.40 | $220,000.00 | (4%) 1.41M to 1.36M | |
19-Jan-24 4:30 PM View: | Lantern Pharma Inc. (LTRN) | 17-Jan-24 | Sale | 58,889 | $4.20 | $247,334.00 | (4%) 1.47M to 1.41M | |
19-Jan-24 4:30 PM View: | Lantern Pharma Inc. (LTRN) | 17-Jan-24 | Exercise (in-the money or at-the-money) | 79,021 | $3.13 | $247,336.00 | 6% 1.39M to 1.47M | |
01-Dec-23 6:00 AM View: | Lantern Pharma Inc. (LTRN) | 29-Nov-23 | Sale Duplicate | 145,348 | $3.44 | $499,997.00 | (9%) 1.53M to 1.39M | |
13-Nov-23 9:48 AM View: | Cognition Therapeutics Inc (CGTX) | 08-Nov-23 | Grant | 500,095 | $1.05 | $525,100.00 | 9% 5.51M to 6.01M | |
23-Jun-23 9:38 PM View: | Azitra, Inc. (AZTR) | 21-Jun-23 | Conversion Duplicate | 4,354,870 | -- | -- | 573% 760.34K to 5.12M | |
23-Jun-23 9:38 PM View: | Azitra, Inc. (AZTR) | 21-Jun-23 | Purchase Duplicate | 2,297,490 | $1.31 | $3,000,000.00 | 45% 5.12M to 7.41M | |
23-Jun-23 9:38 PM View: | Azitra, Inc. (AZTR) | 21-Jun-23 | Sale Duplicate | 669,317 | -- | -- | (9%) 7.41M to 6.74M | |
13-Jun-23 10:00 PM View: | Cognition Therapeutics Inc (CGTX) | 09-Jun-23 | Grant Duplicate | 6,000 | -- | -- | < 1% 5.5M to 5.51M | |
13-Dec-22 7:01 AM View: | In8bio, Inc. (INAB) | 12-Dec-22 | Private Purchase Duplicate | 75,001 | $2.48 | $185,912.00 | < 1% 8.52M to 8.6M | |
29-Nov-22 7:00 AM View: | Cognition Therapeutics Inc (CGTX) | 28-Nov-22 | Private Purchase | 16,064 | $2.65 | $42,564.80 | < 1% 5.48M to 5.5M | |
17-Nov-22 7:00 AM View: | Cognition Therapeutics Inc (CGTX) | 16-Nov-22 | Private Purchase | 71,000 | $1.40 | $99,400.00 | 1% 5.41M to 5.48M | |
16-Nov-22 6:59 AM View: | Cognition Therapeutics Inc (CGTX) | 15-Nov-22 | Private Purchase | 1,500,000 | $1.20 | $1,800,000.00 | 38% 3.91M to 5.41M | |
09-Nov-22 9:39 PM View: | Lantern Pharma Inc. (LTRN) | 08-Nov-22 | Sale Duplicate | 350,000 | $4.40 | $1,540,000.00 | (19%) 1.86M to 1.51M | |
29-Sep-22 6:08 AM View: | In8bio, Inc. (INAB) | 28-Sep-22 | Private Purchase | 25,000 | $2.02 | $50,535.00 | < 1% 8.5M to 8.53M | |
07-Sep-22 4:54 PM View: | Lantern Pharma Inc. (LTRN) | 02-Sep-22 | Sale | 6,445 | $5.20 | $33,514.00 | (< 1%) 1.89M to 1.88M | |
07-Sep-22 4:54 PM View: | Lantern Pharma Inc. (LTRN) | 02-Sep-22 | Exercise (in-the money or at-the-money) | 32,538 | $1.03 | $33,514.10 | 2% 1.86M to 1.89M | |
30-Aug-22 8:10 AM View: | In8bio, Inc. (INAB) | 29-Aug-22 | Purchase | 40,000 | $2.02 | $80,800.00 | < 1% 8.46M to 8.5M | |
30-Aug-22 8:10 AM View: | In8bio, Inc. (INAB) | 26-Aug-22 | Private Purchase | 11,214 | $2.01 | $22,540.10 | < 1% 8.45M to 8.46M | |
18-Aug-22 8:00 PM View: | In8bio, Inc. (INAB) | 17-Aug-22 | Private Purchase Duplicate | 50,000 | $1.93 | $96,500.00 | < 1% 8.4M to 8.45M | |
17-Aug-22 10:27 AM View: | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase Duplicate | 1,773,680 | $1.90 | $3,370,000.00 | 28% 6.37M to 8.14M | |
21-Mar-22 6:11 PM View: | Lantern Pharma Inc. (LTRN) | 17-Mar-22 | Exercise (in-the money or at-the-money) | 95,779 | $160,176.00 | $15,341,500,416.00 | 5% 1.76M to 1.86M | |
03-Aug-21 10:00 PM View: | In8bio, Inc. (INAB) | 03-Aug-21 | Conversion Duplicate | 6,625,100 | -- | -- | 100% 0 to 6.63M | |
16-Jun-20 6:21 PM View: | Lantern Pharma Inc. (LTRN) | 15-Jun-20 | Conversion | 1,456,650 | -- | -- | 478% 304.5K to 1.76M |